The Burden and Determinates of anemia among predialysis chronic kidney disease patients following in renal unit at Tikur Anbessa Specialized Hospital

dc.contributor.advisorMelkie, Addisu(MD, Internist and Consultant in Nephrology)
dc.contributor.advisorSeifu, Lissane(MD, Internist and Consultant in Nephrology )
dc.contributor.authorAbdi, Semir
dc.date.accessioned2021-02-11T07:54:35Z
dc.date.accessioned2023-11-05T09:37:03Z
dc.date.available2021-02-11T07:54:35Z
dc.date.available2023-11-05T09:37:03Z
dc.date.issued2021-02
dc.description.abstractBackground: Anemia is common and significant complication of chronic kidney disease (CKD). Anemia of chronic kidney disease is associated with significant cardiovascular morbidity mortality and poor quality of life. However, its prevalence and management has not been studied thoroughly at local and national level. Objective: To assess the prevalance, severity and management of anemia among predialysis chronic kidney disease (CKD) patients on follow up at Tikur Anbessa Specialized hospital (TASH) renal clinic. Methods and Materials: A hospital based cross sectional hospital study was conducted from April 1 to July 30, 2020. Consecutive sampling was used to recruit 100 study participants. participants were interviewed using structured questionnaire, and their medical records were reviewed to obtain information on relevant medical history and laboratory parameters. Serum Iron panel was determined for all enrolled patients. Data was analyzed using SPSS version 26. Continuous variables were presented as means ± standard deviations and compared by t-test. Categorical variables were expressed as count with percentage and compared by Chi-square. Bivariate and multivariate logistic regression analyses were used to identify independently associated factors of anemia. P-value <0.05 was used to declare association. Results: the burden of anemia in CKD was high (48%) and its prevalence increased with worsening kidney function. Diabetes (40%) and hypertension (25%) were the leading causes of CKD. CKD stage, iron marker and BMI were found to be independent determinant of anemia among CKD patients. Among patients with anemia, only 35.4% were treated, only 27% of patients were managed with iron agent and only 8.3% were managed with ESA. Conclusion: Screening and intervention programs should be implemented to improve the outcome of CKD patients with anemia. Grant source: Addis Ababa University, college of health sciences, school of medicineen_US
dc.identifier.urihttp://etd.aau.edu.et/handle/123456789/25062
dc.language.isoen_USen_US
dc.publisherAddis Abeba Universityen_US
dc.subjectChronic kidney disease, anemia, Ethiopia.en_US
dc.titleThe Burden and Determinates of anemia among predialysis chronic kidney disease patients following in renal unit at Tikur Anbessa Specialized Hospitalen_US
dc.typeThesisen_US

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Semir Abdi.pdf
Size:
302 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description: